PI4KIIIbeta-IN-9 NEW
Price | $73 | $198 | $297 |
Package | 1mg | 5mg | 10mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2024-11-19 |
Product Details
Product Name: PI4KIIIbeta-IN-9 | CAS No.: 1429624-84-9 |
Purity: 97.18% | Supply Ability: 10g |
Release date: 2024/11/19 |
Product Introduction
Bioactivity
Name | PI4KIIIbeta-IN-9 |
Description | PI4KIIIbeta-IN-9 is a potent inhibitor of PI4KIIIβ [IC50 of 7 nM]. |
In vitro | PI4KIIIbeta-IN-9 (Compound 9) exhibits weak inhibition of PI3KC2γ (IC50 ~1 μM), PI3Kα (~2 μM), and PI4KIIIα (~2.6 μM), with less than 50% inhibition up to 20 μM for PI4K2α, PI4K2β, and PI3Kβ. It conforms to the active site of PI4KIIIβ, forming extensive contacts, and inhibits PI3Kδ and PI3Kγ with IC50 values of 152 nM and 1046 nM, respectively. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 4.88 mg/mL (10 mM), Sonication is recommended. |
Keywords | PI4 kinases | inhibit | Inhibitor | Phosphatidylinositol 4 kinases | PI4K | PI3K | PI4KIIIbetaIN9 | PI4KIIIb-IN-9 | Phosphoinositide 3-kinase | PI4KIIIβ-IN-9 | PI-4KIIIbeta-IN-9 | PI4KIIIbeta IN 9 | PI4KIIIbeta-IN-9 |
Inhibitors Related | Myricetin | Erucic acid | Sapanisertib | (2S,3R,4S)-4-Hydroxyisoleucine | Duvelisib (R enantiomer) hydrochloride | Isoprenaline hydrochloride | Quercetin | GDC0084 | Quercetin Dihydrate | Apilimod | LY294002 | Idelalisib |
Related Compound Libraries | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Breast Cancer Compound Library | Angiogenesis related Compound Library | Inhibitor Library | Metabolism Compound Library | Anti-Aging Compound Library | Bioactive Compounds Library Max |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$73.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$1980.00/50mg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2024-10-22 | |
$0.00/1KG |
VIP6Y
|
Hebei Weibang Biotechnology Co., Ltd
|
2024-11-28 | |
$73.00/1mg |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 |
- Since: 2011-01-07
- Address: 36?Washington?Street, Wellesley?Hills
INQUIRY